Gene therapy with drug resistance genes
- 7 October 2005
- journal article
- review article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 13 (4) , 335-345
- https://doi.org/10.1038/sj.cgt.7700912
Abstract
A major side effect of cancer chemotherapy is myelosuppression. Expression of drug-resistance genes in hematopoietic stem cells (HSC) using gene transfer methodologies holds the promise of overcoming marrow toxicity in cancer chemotherapy. Adequate protection of marrow cells in cancer patients from myelotoxicity in this way would permit the use of escalating doses of chemotherapy for eradicating residual disease. A second use of drug-resistance genes is for coexpression with a therapeutic gene in HSCs to provide a selection advantage to gene-modified cells. In this review, we discuss several drug resistance genes, which are well suited for in vivo selection as well as other newer candidate genes with potential for use in this manner.Keywords
This publication has 95 references indexed in Scilit:
- Cloning and Expression of CanineO6-Methylguanine-DNA Methyltransferase in Target Cells, Using Gammaretroviral and Lentiviral VectorsHuman Gene Therapy, 2004
- P-glycoprotein: from genomics to mechanismOncogene, 2003
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Drug-selected co-expression of P-glycoprotein and gp91in vivo from anMDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91The Journal of Gene Medicine, 2003
- Novel Bicistronic Retroviral Vector Expressingγ-Glutamylcysteine Synthetase and the Multidrug Resistance Protein 1 (MRP1) Protects Cells from MRP1-Effluxed Drugs and Alkylating AgentsHuman Gene Therapy, 2001
- Retrovirus-Mediated Gene Transfer of the Human Multidrug Resistance-Associated Protein into Hematopoietic Cells Protects Mice from Chemotherapy-Induced LeukopeniaHuman Gene Therapy, 1999
- Retrovirus-Mediated Gene Transfer of the Multidrug Resistance-Associated Protein (MRP) cDNA Protects Cells from Chemotherapeutic AgentsHuman Gene Therapy, 1997
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.The Journal of Experimental Medicine, 1987